Isolation of human monoclonal antibodies by mammalian cell display

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 38, 2008, Pages 14336-14341

  Beerli, Roger R ^a   Bauer, Monika ^a   Buser, Regula B ^a   Gwerder, Myriam ^a   Muntwiler, Simone ^a   Maurer, Patrik ^a   Saudan, Philippe ^a   Bachmann, Martin F ^a  

^a CYTOS BIOTECHNOLOGY AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; NICOTINE; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY ISOLATION; ANTIBODY LIBRARY; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CELL SURFACE; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HEAVY CHAIN; HUMAN; HUMAN CELL; LIGHT CHAIN; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINDBIS VIRUS; TOBACCO DEPENDENCE; VIRUS EXPRESSION; VIRUS LIKE AGENT;

ALLOLEVIVIRUS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; BRAIN; CAPSID PROTEINS; FLOW CYTOMETRY; HUMANS; IMMUNIZATION, PASSIVE; LEUKOCYTES, MONONUCLEAR; MAMMALS; MICE; NICOTINE; PEPTIDE LIBRARY; SINDBIS VIRUS;

MAMMALIA; SINDBIS VIRUS;

EID: 52949131648     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0805942105     Document Type: Article

References (38)

1. Reichert JM, Rosensweig CJ, Faden LB, Dewitz MC (2005) Monoclonal antibody successes in the clinic. Nat Biotechnol 23:1073-1078.
2. Miller RA, Oseroff AR, Stratte PT, Levy R (1983) Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma. Blood 62:988-995.
3. Ratner B (1943) Allergy, Anaphylaxis and Immunotherapy, Basic Principles and Practice. (Williams and Wilkins, Baltimore).
4. Foote J, Winter G (1992) Antibody framework residues affecting the conformation of the hypervariable loops. J Mol Biol 224:487-499.
5. Riechmann L, Clark M, Waldmann H, Winter G (1988) Reshaping human antibodies for therapy. Nature 332:323-327.
6. Lonberg N (2005) Human antibodies from transgenic animals. Nat Biotechnol 23:1117-1125.
7. Mendez MJ, et al. (1997) Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat Genet 15:146-156.
8. Traggiai E, et al. (2004) An efficient method to make human monoclonal antibodies from memory B cells: Potent neutralization of SARS coronavirus. Nat Med 10:871-875.
9. Weitkamp JH, et al. (2003) Generation of recombinant human monoclonal antibodies to rotavirus from single antigen-specific B cells selected with fluorescent virus-like particles. J Immunol Methods 275:223-237.
10. Hoogenboom HR (2005) Selecting and screening recombinant antibody libraries. Nat Biotechnol 23:1105-1116.
11. Barbas CF, 3rd, Kang AS, Lerner RA, Benkovic SJ (1991) Assembly of combinatorial antibody libraries on phage surfaces: The gene III site. Proc Natl Acad Sci USA 88:7978-7982.
12. Clackson T, Hoogenboom HR, Griffiths AD, Winter G (1991) Making antibody fragments using phage display libraries. Nature 352:624-628.
13. Krebs B, et al. (2001) High-throughput generation and engineering of recombinant human antibodies. J Immunol Methods 254:67-84.
14. Hanes J, Pluckthun A (1997) In vitro selection and evolution of functional proteins by using ribosome display. Proc Natl Acad Sci USA 94:4937-4942.
15. He M, Taussig MJ (1997) Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. Nucleic Acids Res 25:5132-5134.
16. Boder ET, Wittrup KD (1997) Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol 15:553-557.
17. Malin DH, et al. (2001) Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome. Pharmacol Biochem Behav 68:87-92.
18. Maurer P, et al. (2005) A therapeutic vaccine for nicotine dependence: Preclinical efficacy, and Phase I safety and immunogenicity. Eur J Immunol 35:2031-2040.
19. Tissot AC, et al. (2008) Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: A double-blind, randomised, placebo-controlled phase IIa study. Lancet 371:821-827.
20. Gatto D, Ruedl C, Odermatt B, Bachmann MF (2004) Rapid response of marginal zone B cells to viral particles. J Immunol 173:4308-4316.
21. Koller D, et al. (2001) A high-throughput alphavirus-based expression cloning system for mammalian cells. Nat Biotechnol 19:851-855.
22. Sirena D, et al. (2004) The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. J Virol 78:4454-4462.
23. Friguet B, Chaffotte AF, Djavadi-Ohaniance L, Goldberg ME (1985) Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Methods 77:305-319.
24. Meijer PJ, et al. (2006) Isolation ofhumanantibody repertoires with preservation of the natural heavy and light chain pairing. J Mol Biol 358:764-772.
25. Keyler DE, et al. (2005) Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: Dose- and affinity-response relationships. Drug Metab Dispos 33:1056-1061.
26. Maurer P, Bachmann MF (2007) Vaccination against nicotine: An emerging therapy for tobacco dependence. Expert Opin Investig Drugs 16:1775-1783.
27. Lindblom N, et al. (2002) Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats. Respiration 69:254-260.
28. Celie PH, et al. (2004) Nicotine and carbamylcholine binding to nicotinic acetylcholine receptors as studied in AChBP crystal structures. Neuron 41:907-914.
29. Benowitz NL, Zevin S, Jacob P, 3rd (1997) Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. Br J Clin Pharmacol 43:259-267.
30. Mazor Y, Van Blarcom T, Mabry R, Iverson BL, Georgiou G (2007) Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli. Nat Biotechnol 25:563-565.
31. Bowley DR, Labrijn AF, Zwick MB, Burton DR (2007) Antigen selection from an HIV-1 immune antibody library displayed on yeast yields many novel antibodies compared to selection from the same library displayed on phage. Protein Eng Des Sel 20:81-90.
32. Ho M, Nagata S, Pastan I (2006) Isolation of anti-CD22 Fv with high affinity by Fv display on human cells. Proc Natl Acad Sci USA 103:9637-9642.
33. Barbas CF, 3rd, Burton DR, Scott JK, Silverman GJ (2001) Phage Display: A Laboratory Manual (Cold Spring Harbor Lab Press, Cold Spring Harbor, NY).
34. Lagerkvist AC, Furebring C, Borrebaeck CA (1995) Single, antigen-specific B cells used to generate Fab fragments using CD40-mediated amplification or direct PCR cloning. BioTechniques 18:862-869.
35. Galle P, Svenson M, Bendtzen K, Hansen MB (2004) High levels of neutralizing IL-6 autoantibodies in 0.1% of apparently healthy blood donors. Eur J Immunol 34:3267-3275.
36. Jouvenne P, Fossiez F, Banchereau J, Miossec P (1997) High levels of neutralizing autoantibodies against IL-1 alpha are associated with a better prognosis in chronic polyarthritis: A follow-up study. Scand J Immunol 46:413-418.
37. Scaviner D, Barbie V, Ruiz M, Lefranc MP (1999) Protein displays of the human immunoglobulin heavy, kappa and lambda variable and joining regions. Exp Clin Immunogenet 16:234-240.
38. Bredenbeek PJ, Frolov I, Rice CM, Schlesinger S (1993) Sindbis virus expression vectors: Packaging of RNA replicons by using defective helper RNAs. J Virol 67:6439-6446.